Cartesian Therapeutics, Inc.·4

Dec 8, 4:07 PM ET

BARABE TIMOTHY C 4

4 · Cartesian Therapeutics, Inc. · Filed Dec 8, 2025

Insider Transaction Report

Form 4
Period: 2025-12-04
Transactions
  • Purchase

    Common Stock

    2025-12-04$6.86/sh+30,000$205,79754,366 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.80 to $6.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    wk-form4_1765228029.xmlPrimary

    FORM 4